Revenue
312 thousand USD
2013 · USD
Exact inputs and evidence
- Revenue: 312200 USD Source
Market value is not computed: no recent price is available.
78 filing records in this dataset, filed from 2001-10-15 to 2023-01-18. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-19; this is not a statement that none were filed.
244038890 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
-63.8 thousand USD
2021-12-01 – 2022-11-30
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2023-01-18.
Financial data available through: 2022-11-30.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 57,028
–
Current period
−USD 65,792
–
-65792 − -57028 = -8764 USD
-57028 USD · 2020-12-01 – 2021-11-30
Inspect prior input Prior source-65792 USD · 2021-12-01 – 2022-11-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 55,000
–
Current period
−USD 63,764
–
-63764 − -55000 = -8764 USD
-55000 USD · 2020-12-01 – 2021-11-30
Inspect prior input Prior source-63764 USD · 2021-12-01 – 2022-11-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2013 2012-12-01 – 2013-11-30 | 312200 | 686388 Derived | -374188 | 161498 Derived | -535686 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2013 | Revenue | 312200 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2013 | Year over year | No prior comparable period |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2013 | Operating margin | -119.9% |
|
| 2013 | Net margin | -171.6% |
|
| 2013 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2013 | Operating cash flow | 32895 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2013 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2013-11-30 | Liabilities / assets | Not reported |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2013 | Current assets / current liabilities | 0.14× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2012 2011-12-01 – 2012-11-30 | −USD 392,964 Exact valueExact value: -392964 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 23,670 Exact valueExact value: -23670 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2013 2012-12-01 – 2013-11-30 | −USD 535,686 Exact valueExact value: -535686 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 32,895 Exact valueExact value: 32895 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-12-01 – 2021-11-30 | −USD 57,028 Exact valueExact value: -57028 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 55,000 Exact valueExact value: -55000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-12-01 – 2022-11-30 | −USD 65,792 Exact valueExact value: -65792 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 63,764 Exact valueExact value: -63764 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
78 filings · 425 latest values · 425 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001126162, 1126162, PURT, edgar:1126162
Also known as Global Biotech Corp., PURTHANOL RESOURCES LIMITED, PURTHANOL RESOURCES LTD., Purthanol Resources Ltd, SWORD COMP SOFT CORP